Evaluating Quality and Cost of (Partial) Oncological Home-Hospitalization

General Hospital Groeninge

Status: Completed

Conditions: Cancer

Treatments: Procedure: (partial) oncological home-hospitalization

Study type: Interventional

Funder types: Other

Identifiers

NCT03668275

AZGS2017075

Details and patient eligibility

About

Oncological home-hospitalization might be a patient-centred, cost-effective approach to deal wiht the current challenges in cancer healthcare.

The primary aim of this clinical trial is to evaluate patient-reported quality of life of patients receiving (partial) oncological home-hospitalization and to compare this outcome with patients receiving standard ambulatory hospital care.

Secondary endpoints that will be evaluated and compared between both randomized groups are: Quality of life related endpoints (i.e. distress, depression & anxiety and general health-related quality of life); Costs; Safety; patients' reported Satisfaction & Preferences and Efficiency for the hospital day care unit.

Enrollment: 148 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Starting new oncological treatment at the outpatient hospital
• ECOG ≤ 2
• Living within 30 minutes of drive from the hospital

Exclusion criteria

• Important comorbidity (ECOG > 2)
• Life expectancy < 6 months
• Simultaneous treatment with radiotherapy
• Taking part in clinical trial with any Investigational Medicinal Product
• Language barriers or communication difficulties
• Problematic venous access

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

148 participants in 2 patient groups

Intervention

Experimental group

Description:

(partial) oncological home-hospitalization

Treatment:

Procedure: (partial) oncological home-hospitalization

Control

No Intervention group

Description:

standard oncological ambulatory hospital care